{"id":"https://openalex.org/W4310106417","doi":"https://doi.org/10.1182/blood-2022-165458","title":"The Composition of Acute Myeloid Leukemia Cell Differentiation States Predicts Response to Immune Checkpoint Blockade","display_name":"The Composition of Acute Myeloid Leukemia Cell Differentiation States Predicts Response to Immune Checkpoint Blockade","publication_year":2022,"publication_date":"2022-11-15","ids":{"openalex":"https://openalex.org/W4310106417","doi":"https://doi.org/10.1182/blood-2022-165458"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2022-165458","doi":"https://doi.org/10.1182/blood-2022-165458","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2022-165458","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5063974603","display_name":"Joseph Cataquiz Rimando","orcid":"https://orcid.org/0000-0002-4127-2091","observed_orcids":["https://orcid.org/0000-0002-4127-2091"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph Rimando","raw_affiliation_strings":["1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I4210164401"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022931646","display_name":"Leslie Cope","orcid":"https://orcid.org/0000-0002-4098-3289","observed_orcids":["https://orcid.org/0000-0002-4098-3289"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leslie Cope","raw_affiliation_strings":["1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I4210164401"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005855096","display_name":"Karen P. McKinnon","orcid":"https://orcid.org/0000-0002-1779-5626","observed_orcids":["https://orcid.org/0000-0002-1779-5626"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karen McKinnon","raw_affiliation_strings":["2Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020894945","display_name":"Benjamin Garrett Vincent","orcid":"https://orcid.org/0000-0002-1762-2282","observed_orcids":["https://orcid.org/0000-0002-1762-2282"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Benjamin G. Vincent","raw_affiliation_strings":["2Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029407987","display_name":"Sergio Rutella","orcid":"https://orcid.org/0000-0003-1970-7375","observed_orcids":["https://orcid.org/0000-0003-1970-7375"]},"institutions":[{"id":"https://openalex.org/I52590639","display_name":"Nottingham Trent University","ror":"https://ror.org/04xyxjd90","country_code":"GB","type":"education","lineage":["https://openalex.org/I52590639"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Sergio Rutella","raw_affiliation_strings":["3John van Geest Cancer Research Centre, Nottingham Trent University, Nottingham, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3John van Geest Cancer Research Centre, Nottingham Trent University, Nottingham, United Kingdom","institution_ids":["https://openalex.org/I52590639"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040303721","display_name":"Joshua F. Zeidner","orcid":"https://orcid.org/0000-0002-9014-1514","observed_orcids":["https://orcid.org/0000-0002-9014-1514"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joshua F. Zeidner","raw_affiliation_strings":["4UNC - Lineberger Comprehensive Cancer Center, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4UNC - Lineberger Comprehensive Cancer Center, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026510629","display_name":"Jonathan Stuart Serody","orcid":"https://orcid.org/0000-0003-4568-1092","observed_orcids":["https://orcid.org/0000-0003-4568-1092"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jonathan S. Serody","raw_affiliation_strings":["5Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046719320","display_name":"Ivana Gojo","orcid":"https://orcid.org/0000-0003-0312-3412","observed_orcids":["https://orcid.org/0000-0003-0312-3412"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ivana Gojo","raw_affiliation_strings":["1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I4210164401"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5014659694","display_name":"Leo Luznik","orcid":"https://orcid.org/0009-0005-7951-5190","observed_orcids":["https://orcid.org/0009-0005-7951-5190"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leo Luznik","raw_affiliation_strings":["1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I4210164401"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2500,"currency":"USD","value_usd":2500},"apc_paid":null,"fwci":0.5453,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.68203357,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":97},"biblio":{"volume":"140","issue":"Supplement 1","first_page":"6314","last_page":"6315"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.007499999832361937,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9990000128746033},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.9639999866485596},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9950000047683716},{"id":"https://openalex.org/keywords/tumor-infiltrating-immune-cells","display_name":"tumor-infiltrating immune cells","score":0.5220000147819519},{"id":"https://openalex.org/keywords/allogeneic-t-cells","display_name":"allogeneic T cells","score":0.7670000195503235},{"id":"https://openalex.org/keywords/myeloid-derived-suppressor-cells","display_name":"myeloid-derived suppressor cells","score":0.6850000023841858},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.6579999923706055},{"id":"https://openalex.org/keywords/treatment-response-prediction","display_name":"treatment response prediction","score":0.5389999747276306}],"concepts":[{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.6497055888175964},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.5376952886581421},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.49531474709510803},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4342942535877228},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.41617321968078613},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.41217243671417236},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3769599497318268},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.225182443857193},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.12078920006752014}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2022-165458","doi":"https://doi.org/10.1182/blood-2022-165458","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2022-165458","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3206235705","https://openalex.org/W4417020808","https://openalex.org/W6907927109","https://openalex.org/W3094904715","https://openalex.org/W4405042416","https://openalex.org/W3211352653","https://openalex.org/W4310105159","https://openalex.org/W4411288282","https://openalex.org/W3126236136","https://openalex.org/W2985442439"],"abstract_inverted_index":{"Background:":[0],"Given":[1],"the":[2,217,227,232,251,263,366,397,514,608],"activity":[3],"of":[4,51,77,92,116,219,231,267,327,431,459,481,508,552,563,607,610],"allogeneic":[5,618],"T":[6,17,573],"cells":[7,55,82,465,485,574,580],"in":[8,58,121,143,214,272,595,602,614],"acute":[9],"myeloid":[10],"leukemia":[11,460,509],"(AML)":[12],"patients,":[13],"immunotherapies":[14],"stimulating":[15],"antitumor":[16,572],"cell":[18,64,118,269,334,380,407,620],"responses":[19],"have":[20,31,83],"been":[21,32,67,84,130],"explored":[22,134],"as":[23,221,279,295,336],"a":[24,325,353,456,560,596],"promising":[25],"therapeutic":[26],"option.":[27],"However,":[28],"these":[29,422,593],"therapies":[30],"associated":[33,85,140,206,527,536],"with":[34,86,141,147,171,182,216,528,537],"modest":[35],"clinical":[36,88,207],"activity,":[37],"and":[38,46,53,62,80,90,153,166,173,176,186,205,254,290,302,312,329,332,348,383,400,413,437,462,498,522,531,547,566,584,598,601],"further":[39],"research":[40,223,588],"is":[41,589],"needed":[42,590],"to":[43,70,94,123,357,392,453,474,492,545,591],"identify":[44],"response":[45,93,125,142,355],"resistance":[47,127],"mechanisms.":[48],"A":[49],"spectrum":[50],"primitive":[52,328],"differentiated":[54,330,368,553,578],"comprise":[56],"AML":[57,78,117,144,168,179,268,331,369,385,402,417,432,484,554,564,579,582,611],"each":[59],"individual":[60],"patient,":[61],"this":[63,136],"composition":[65,115,137],"has":[66,128],"previously":[68],"shown":[69],"predict":[71],"outcomes.":[72],"In":[73,513],"particular,":[74],"high":[75],"proportions":[76,480,551,609],"stem":[79,399,406,461,565,583],"progenitor":[81,401,410,415,463,567,585],"worse":[87],"outcomes":[89],"lack":[91],"induction":[95],"chemotherapy":[96],"(Ng":[97],"et":[98,104,109,190,282,298,304,340,445],"al":[99,105,110,191,283,299,305,341,446],"Nature":[100,300],"2016;":[101],"van":[102,338],"Galen":[103,339],"Cell":[106,342],"2019;":[107],"Zeng":[108,281,303,444],"Nat":[111,284,306,447],"Med":[112,285,307,448],"2022).":[113],"The":[114,287],"differentiation":[119,433,612],"states":[120,434,613],"relation":[122],"immunotherapy":[124,359,604],"or":[126],"not":[129,389,451,490],"elucidated;":[131],"herein,":[132],"we":[133],"whether":[135],"may":[138,575],"be":[139],"patients":[145,169,180,471,489,558,615],"treated":[146,170,181],"immune":[148],"checkpoint":[149],"blockade.":[150],"Methods:":[151],"Pre-":[152],"posttreatment":[154,349,515],"whole":[155],"bone":[156],"marrow":[157],"(BM)":[158],"samples":[159,204,274,425],"were":[160,209,275,293,314,361,394,426,526,535],"collected":[161],"from":[162,324,443],"31":[163],"newly":[164],"diagnosed":[165],"relapsed/refractory":[167,178],"azacitidine":[172],"pembrolizumab":[174,187],"(NCT02845297)":[175],"18":[177],"high-dose":[183],"cytarabine":[184],"(HiDAC)":[185],"(NCT02768792;":[188],"Zeidner":[189],"Blood":[192],"Cancer":[193],"Discov":[194],"2022)":[195],"on":[196,240,346],"two":[197,501],"separate":[198],"phase":[199],"II":[200],"trials.":[201],"Primary":[202],"patient":[203],"data":[208,442],"obtained":[210],"via":[211],"informed":[212],"consent":[213],"accordance":[215],"Declaration":[218],"Helsinki":[220],"per":[222,280,296,337],"protocols":[224],"approved":[225],"by":[226],"Institutional":[228],"Review":[229],"Boards":[230],"participating":[233],"institutions.":[234],"Bulk":[235],"RNA":[236,439],"sequencing":[237,440],"was":[238,248,260,344],"performed":[239,249,261,345],"all":[241],"BM":[242,273,424],"samples.":[243,350],"Differential":[244],"gene":[245,255,322,370,403,502,524,533],"expression":[246,441,503],"analysis":[247,258],"using":[250,262,277,316,321,435],"DESeq2":[252],"package,":[253],"set":[256],"enrichment":[257],"(GSEA)":[259],"clusterProfiler":[264],"package.":[265],"Proportions":[266],"populations":[270],"present":[271],"deconvoluted":[276,427],"CIBERSORTx":[278,436],"2022.":[286,449],"LSC17":[288,497],"score":[289,292],"LinClass7":[291,499],"calculated":[294],"Ng":[297],"2016":[301],"2022,":[308],"respectively.":[309],"All":[310],"analyses":[311],"graphs":[313],"generated":[315],"R":[317],"(v4.2.1).":[318],"Results:":[319],"GSEA":[320],"sets":[323,525,534],"range":[326],"normal":[333],"types":[335],"2019":[343],"pre-":[347],"Patients":[351,388,450,542],"achieving":[352,472,543],"complete":[354],"(CR)":[356],"either":[358,475],"regimen":[360,476],"enriched":[362,395],"at":[363,468],"baseline":[364,479,496],"for":[365,396,517],"following":[367,398],"sets:":[371,404],"pro":[372,482],"monocyte":[373],"(Promono)-like":[374],"AML;":[375,377,382,409,412],"monocyte-like":[376,483,530],"conventional":[378],"dendritic":[379],"(cDC)-like":[381],"myeloid-like":[384,532],"(Figure":[386,418,486,511,539],"1A).":[387,419,540],"responding":[390,452,491],"(NR)":[391],"azacitidine/pembrolizumab":[393,454,493,546],"hematopoietic":[405,619],"(HSC)-like":[408],"(Prog)-like":[411],"HSC":[414],"(HSCProg)-like":[416],"To":[420],"validate":[421,592],"findings,":[423],"into":[428],"inferred":[429],"fractions":[430],"single-cell":[438],"had":[455,477,494,549,559],"higher":[457,478,495,550,561],"proportion":[458,562],"quiescent":[464],"(LSPC":[466],"Quiescent)":[467],"baseline,":[469],"while":[470,556],"CR":[473,538,544],"1B).":[487,512],"Additionally,":[488],"scores,":[500],"scores":[504],"that":[505,571],"are":[506,622],"reflective":[507],"stemness":[510],"setting":[516],"both":[518],"regimens,":[519],"HSC-like,":[520],"Prog-like,":[521],"HSCProg-like":[523],"NR;":[529],"Discussion:":[541],"HiDAC/pembrolizumab":[548],"cells,":[555],"NR":[557],"cells.":[568,586],"We":[569],"hypothesize":[570],"preferentially":[576],"target":[577],"over":[581],"Further":[587],"findings":[594],"prospective":[597],"mechanistic":[599],"manner":[600],"other":[603],"regimens.":[605],"Analyses":[606],"relapsing":[616],"after":[617],"transplantation":[621],"ongoing.":[623],"Figure":[624],"1View":[625,628],"largeDownload":[626,629],"PPTFigure":[627],"PPT":[630],"Close":[631],"modal":[632]},"counts_by_year":[{"year":2023,"cited_by_count":3}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2022-11-30T00:00:00"}